Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Constipation: Occurred in 18.8% of patients on semaglutide in the STEP-1 trial, compared to 6.8% in the placebo group
As this class of medications continues to expand, understanding the GI implications of each receptor target becomes increasingly important
Diabetes and high blood pressure are the leading causes of CKD, so people with high blood pressure or blood glucose levels need to be particularly vigilant about monitoring their kidney function
UTIs occurring during Wegovy treatment are likely coincidental or related to independent risk factors such as female anatomy, diabetes, or menopausal status
The timeline varies significantly
US$ 23.00
US$ 23.32
US$ 25.51
US$ 27.58
US$ 25.33
US$ 25.08
US$ 22.27
US$ 23.97
US$ 24.03
